Nintedanib 100mg capsules
NHS hospitals in England used £96,078,540 of indicative cost of Nintedanib 100mg capsules in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is up 95.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nintedanib 100mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nintedanib 100mg capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £17,556,567 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £8,617,445 |
| Oxford University Hospitals Nhs Ft | £6,943,464 |
| Royal Papworth Hospital Nhs Ft | £6,390,749 |
| Manchester University Nhs Ft | £5,073,665 |
| Leeds Teaching Hpls Nhs Trust | £4,436,128 |
| Imperial College Healthcare Nhs Trust | £4,351,480 |
| Nottingham University Hospitals Trust | £4,344,450 |
| University College London Foundation Tr | £3,464,813 |
| Royal Devon & Exeter Nhs Foundation Trst | £3,413,203 |
The primary-care picture
Nintedanib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nintedanib medicine page.